| Recommendations for pathology peer review. | |
| | |
MedLine Citation:
|
PMID: 20924082 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pathology peer review verifies and improves the accuracy and quality of pathology diagnoses and interpretations. Pathology peer review is recommended when important risk assessment or business decisions are based on nonclinical studies. For pathology peer review conducted before study completion, the peer-review pathologist reviews sufficient slides and pathology data to assist the study pathologist in refining pathology diagnoses and interpretations. Materials to be reviewed are selected by the peer-review pathologist. Consultations with additional experts or a formal (documented) pathology working group may be used to resolve discrepancies. The study pathologist is solely responsible for the content of the final pathology data and report, makes changes resulting from peer-review discussions, initiates the audit trail for microscopic observations after all changes resulting from peer-review have been made, and signs the final pathologist's report. The peer-review pathologist creates a signed peer-review memo describing the peer-review process and confirming that the study pathologist's report accurately and appropriately reflects the pathology data. The study pathologist also may sign a statement of consensus. It is not necessary to archive working notes created during the peer-review process. |
| | |
Authors:
|
Daniel Morton; Rani S Sellers; Erio Barale-Thomas; Brad Bolon; Catherine George; Jerry F Hardisty; Armando Irizarry; Jennifer S McKay; Marielle Odin; Munehiro Teranishi |
Publication Detail:
|
Type: Journal Article Date: 2010-10-05 |
Journal Detail:
|
Title: Toxicologic pathology Volume: 38 ISSN: 1533-1601 ISO Abbreviation: Toxicol Pathol Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2011-01-20 Completed Date: 2011-04-19 Revised Date: 2012-01-05 |
Medline Journal Info:
|
Nlm Unique ID: 7905907 Medline TA: Toxicol Pathol Country: United States |
Other Details:
|
Languages: eng Pagination: 1118-27 Citation Subset: IM |
Affiliation:
|
Pfizer Inc, Groton, Connecticut, USA. dan.g.morton@pfizer.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Evaluation, Preclinical / standards Health Planning Guidelines* Humans Pathology / standards* Peer Review / methods* Risk Assessment Toxicology / standards* |
| Comments/Corrections | |
Comment In:
|
Toxicol Pathol. 2010 Dec;38(7):1009-10
[PMID:
21248323
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thyroid follicular lesions induced by oral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-d...
Next Document: Evaluating the roles of energetic functional constraints on teleost mitochondrial-encoded protein ev...